Chief Accounting Officer
Immunome Inc. (IMNM)Equibles does not estimate personal net worth.
Get an email with a short summary when Immunome Inc. publishes a filing, an earnings call transcript or a press release.
Get IMNM alertsBob Lapetina is recorded as Chief Accounting Officer at Immunome Inc. (IMNM) since January 2, 2024. Immunome Inc. reported in an 8-K filed April 30, 2024 that Bob Lapetina resigned as Vice President, Finance, Corporate Controller, and principal accounting officer, effective May 10, 2024. Immunome Inc. reported in an 8-K filed December 29, 2023 that Bob Lapetina was appointed principal accounting officer, effective January 2, 2024. Immunome Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Immunome Inc. includes Clay B. Siegall, Ph.D. (CEO), Clay Siegall (CEO), Corleen Roche (CFO) and 7 others.
“On April 24, 2024, Bob Lapetina notified Immunome, Inc. (the "Company") that he will be resigning from his positions as the Company's Vice President, Finance, Corporate Controller, and principal accounting officer to pursue other opportunities.”
“The Company's board of directors has, effective as of the Roche Separation Date, appointed Bob Lapetina, in addition to his other titles, as the Company's principal accounting officer.”
2024-01-02–present
2024-01-02–2024-05-10
Proxy statement
Start not stated–2024-05-10
IMNM
Biotechnology · Healthcare
Chief Accounting Officer
2024-01-02–present
